HF Advisory Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,565
Closed -$517K 173
2025
Q4
$517K Sell
1,565
-993
-39% -$337K 0.18% 128
2025
Q3
$883K Buy
2,558
+866
+51% +$262K 0.32% 100
2025
Q2
$528K Buy
1,692
+282
+20% +$108K 0.21% 123
2025
Q1
$738K Buy
1,410
+147
+12% +$75.1K 0.32% 106
2024
Q4
$639K Buy
1,263
+64
+5% +$36.4K 0.29% 110
2024
Q3
$701K Sell
1,199
-59
-5% -$33.4K 0.33% 108
2024
Q2
$640K Sell
1,258
-282
-18% -$138K 0.33% 105
2024
Q1
$762K Buy
1,540
+251
+19% +$128K 0.43% 84
2023
Q4
$678K Buy
1,289
+448
+53% +$239K 0.43% 85
2023
Q3
$433K Buy
841
+106
+14% +$52.2K 0.32% 103
2023
Q2
$353K Sell
735
-55
-7% -$26.9K 0.28% 107
2023
Q1
$373K Buy
790
+131
+20% +$63.2K 0.33% 96
2022
Q4
$349K Buy
+659
New +$349K 0.35% 92

Other funds holding UNH

HF Advisory Group's UNH Position: Q1 2026 in Review

HF Advisory Group sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 1,565 shares — an estimated $517K sold.

HF Advisory Group first reported a position in UNH in Q4 2022 and held it in 13 quarters. The position peaked at $883K in Q3 2025. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • HF Advisory Group reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • HF Advisory Group sold 1,565 UnitedHealth shares in Q1 2026, an estimated $517K.
  • HF Advisory Group first reported a position in UnitedHealth in Q4 2022 and held it in 13 quarters.
  • HF Advisory Group's UnitedHealth position peaked at $883K in Q3 2025.
  • 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on HF Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.